These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 26166020)
1. Comparison of 2-year outcomes of repeated second-generation drug-eluting stent implantation for focal-type versus nonfocal-type in-stent restenosis. Zhu W; Li J; Luo H; Wang G; Hua Q Coron Artery Dis; 2015 Nov; 26(7):587-91. PubMed ID: 26166020 [TBL] [Abstract][Full Text] [Related]
2. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis. Zhao L; Zhu W; Zhang X; He D; Guo C BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis. Almalla M; Schröder J; Pross V; Marx N; Hoffmann R Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ; JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063 [TBL] [Abstract][Full Text] [Related]
5. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
7. Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents. Almalla M; Schröder JW; Pross V; Marx N; Hoffmann R Coron Artery Dis; 2013 Mar; 24(2):165-70. PubMed ID: 23242011 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation. Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]). Ko YG; Kim JS; Kim BK; Choi D; Hong MK; Jeon DW; Yang JY; Ahn YK; Jeong MH; Yu CW; Yun KH; Lim DS; Jang Y; Am J Cardiol; 2012 Mar; 109(5):607-13. PubMed ID: 22172241 [TBL] [Abstract][Full Text] [Related]
10. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis. Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. Latib A; Mussardo M; Ielasi A; Tarsia G; Godino C; Al-Lamee R; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A JACC Cardiovasc Interv; 2011 Feb; 4(2):155-64. PubMed ID: 21349453 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. Lee MS; Yang T; Mahmud E; Park KW; Kim HS; Kim MH; Dangas G; Hermiller J; Krucoff M; Rutledge D J Invasive Cardiol; 2014 Sep; 26(9):420-6. PubMed ID: 25198484 [TBL] [Abstract][Full Text] [Related]
14. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis. Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553 [TBL] [Abstract][Full Text] [Related]
15. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention. Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511 [TBL] [Abstract][Full Text] [Related]
16. Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations. Naganuma T; Latib A; Costopoulos C; Oreglia J; Testa L; De Marco F; Candreva A; Chieffo A; Naim C; Montorfano M; Bedogni F; Colombo A EuroIntervention; 2016 Jan; 11(9):989-95. PubMed ID: 25405656 [TBL] [Abstract][Full Text] [Related]
17. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Solinas E; Dangas G; Kirtane AJ; Lansky AJ; Franklin-Bond T; Boland P; Syros G; Kim YH; Gupta A; Mintz G; Fahy M; Collins M; Kodali S; Stone GW; Moses JW; Leon MB; Mehran R Am J Cardiol; 2008 Aug; 102(3):311-5. PubMed ID: 18638592 [TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients. Jeong HS; Cho JY; Kim EJ; Yu CW; Ahn CM; Park JH; Hong SJ; Lim DS Coron Artery Dis; 2013 Dec; 24(8):676-83. PubMed ID: 23994881 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G; EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062 [TBL] [Abstract][Full Text] [Related]
20. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]). Alfonso F; Pérez-Vizcayno MJ; Dutary J; Zueco J; Cequier A; García-Touchard A; Martí V; Lozano I; Angel J; Hernández JM; López-Mínguez JR; Melgares R; Moreno R; Seidelberger B; Fernández C; Hernandez R; JACC Cardiovasc Interv; 2012 Jul; 5(7):728-37. PubMed ID: 22814777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]